首页|Fondazione IRCCS Casa Sollievo della Sofferenza Reports Findings in Artificial I ntelligence (Inflammatory bowel disease genomics, transcriptomics, proteomics an d metagenomics meet artificial intelligence)
Fondazione IRCCS Casa Sollievo della Sofferenza Reports Findings in Artificial I ntelligence (Inflammatory bowel disease genomics, transcriptomics, proteomics an d metagenomics meet artificial intelligence)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Artificial Intelligenc e is the subject of a report. According to news reporting originating from San G iovanni Rotondo, Italy, by NewsRx correspondents, research stated, “Various extr insic and intrinsic factors such as drug exposures, antibiotic treatments, smoki ng, lifestyle, genetics, immune responses, and the gut microbiome characterize u lcerative colitis and Crohn’s disease, collectively called inflammatory bowel di sease (IBD). All these factors contribute to the complexity and heterogeneity of the disease etiology and pathogenesis leading to major challenges for the scien tific community in improving management, medical treatments, genetic risk, and e xposome impact.” Our news editors obtained a quote from the research from Fondazione IRCCS Casa S ollievo della Sofferenza, “Understanding the interaction(s) among these factors and their effects on the immune system in IBD patients has prompted advances in multi-omics research, the development of new tools as part of system biology, an d more recently, artificial intelligence (AI) approaches. These innovative appro aches, supported by the availability of big data and large volumes of digital me dical datasets, hold promise in better understanding the natural histories, pred ictors of disease development, severity, complications and treatment outcomes in complex diseases, providing decision support to doctors, and promising to bring us closer to the realization of the ‘precision medicine’ paradigm.”
San Giovanni RotondoItalyEuropeArt ificial IntelligenceBowel Diseases and ConditionsDigestive System Diseases a nd ConditionsDrugs and TherapiesEmerging TechnologiesGastroenteritisGast rointestinal Diseases and ConditionsGeneticsHealth and MedicineInflammator y Bowel DiseaseMachine LearningProteomicsRisk and Prevention
NETL
NSTL
